Inventor · disambiguated record
Tedd D. Elich
Also filed as: ELICH TEDD D
23 granted patents·21 pending applications·145 citations·filing 1999–2025
94Inventor score
Files withLIFEEDIT THERAPEUTICS INC16LIFE EDIT THERAPEUTICS INC14MONSANTO TECHNOLOGY LLC8ELICH TEDD D3BROWN SHERRI M1
Top patents by PatentIndex Score
44 records- 0195US11981916B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·2 cites·38 claims
- 0295US11162114B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2019·Granted Nov 2, 2021·11 cites·19 claims
- 0391US2025084393A1Nucleic acid molecules encoding dna modifying enzymes and active fragments and variants thereof and compositions comprising the sameLIFE EDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0490US12252718B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·0 cites·20 claims
- 0590US12188062B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Jan 7, 2025·0 cites·20 claims
- 0690US12188061B2Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the sameLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Jan 7, 2025·0 cites·22 claims
- 0790US6723897B2Methods for controlling gibberellin levelsMONSANTO TECHNOLOGY LLC·Filed 1999·Granted Apr 20, 2004·107 cites·1 claims
- 0890US2025066753A1Dna modifying enzymes and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0989US12252706B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·0 cites·28 claims
- 1088US12338455B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Jun 24, 2025·0 cites·19 claims
- 1188US2025092398A1Polypeptides useful for gene editing and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1287US7195917B2Methods for controlling gibberellin levelsMONSANTO TECHNOLOGY LLC·Filed 2003·Granted Mar 27, 2007·16 cites·10 claims
- 1387US2025066783A1Polypeptides useful for gene editing and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1486US12473539B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Nov 18, 2025·0 cites·29 claims
- 1586US12435325B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Oct 7, 2025·0 cites·30 claims
- 1686US12398385B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Aug 26, 2025·0 cites·29 claims
- 1785US12188018B2Polypeptides useful for gene editing and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·28 claims
- 1885US2024026384A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1983US11981940B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·0 cites·18 claims
- 2083US11859181B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted Jan 2, 2024·0 cites·18 claims
- 2182US12398384B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2022·Granted Aug 26, 2025·0 cites·16 claims
- 2282US9447423B2Regulatory polynucleotides and uses thereofELICH TEDD D·Filed 2011·Granted Sep 20, 2016·4 cites·20 claims
- 2381US8816152B2Regulatory polynucleotides and uses thereofELICH TEDD D·Filed 2012·Granted Aug 26, 2014·4 cites·17 claims
- 2480US2023175018A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2580US2025283117A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2678US2025250554A1Dna modifying enzymes and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2777US11926843B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·0 cites·28 claims
- 2876US2025179529A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2974US12188028B1Methods for making genetic regulatory elementsMONSANTO TECHNOLOGY LLC·Filed 2017·Granted Jan 7, 2025·1 cites·14 claims
- 3072US2022145296A1Polypeptides useful for gene editing and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3171US11932862B1Genetic regulatory elementsMONSANTO TECHNOLOGY LLC·Filed 2021·Granted Mar 19, 2024·0 cites·22 claims
- 3260US2024271162A1Rna polymerase iii promoters and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3359US2014331358A1Regulatory polynucleotides and uses thereofMONSANTO TECHNOLOGY LLC·Filed 2014·Application pending·0 cites
- 3459US2015033407A1Regulatory polynucleotides and uses thereofMONSANTO TECHNOLOGY LLC·Filed 2014·Application pending·0 cites
- 3559US2024301385A1Dna modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3658US10030248B2Regulatory polynucleotides and uses thereofMONSANTO TECHNOLOGY LLC·Filed 2016·Granted Jul 24, 2018·0 cites·18 claims
- 3758US2007174931A1Methods for controlling gibberellin levelsBROWN SHERRI M·Filed 2007·Application pending·0 cites
- 3856US2023203463A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3955US2024247242A1Uracil stabilizing proteins and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4055US2022364074A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4152US11377663B1Genetic regulatory elementsDAVIS IAN W·Filed 2012·Granted Jul 5, 2022·0 cites·26 claims
- 4242US2014230093A1Regulatory polynucleotides and uses thereofMONSANTO TECHNOLOGY LLC·Filed 2012·Application pending·0 cites
- 4341US2014237682A1Regulatory polynucleotides and uses thereofELICH TEDD D·Filed 2012·Application pending·0 cites
- 4437US2009215627A1Crystal Structure of Biotin Carboxylase (Bc) Domain of Acetyl-Coenzyme a Carboxylase and Methods of Use ThereofSHEN YANG·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tedd D. Elich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →